2-240757423-ATCCTCCTCCTCCTCCTCC-ATCCTCCTCCTCCTCC

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBA1

The NM_001244008.2(KIF1A):​c.2751_2753delGGA​(p.Glu917del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.521 in 1,443,684 control chromosomes in the GnomAD database, including 157,487 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.65 ( 28069 hom., cov: 0)
Exomes 𝑓: 0.51 ( 129418 hom. )

Consequence

KIF1A
NM_001244008.2 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 3.22

Publications

17 publications found
Variant links:
Genes affected
KIF1A (HGNC:888): (kinesin family member 1A) The protein encoded by this gene is a member of the kinesin family and functions as an anterograde motor protein that transports membranous organelles along axonal microtubules. Mutations at this locus have been associated with spastic paraplegia-30 and hereditary sensory neuropathy IIC. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Apr 2012]
KIF1A Gene-Disease associations (from GenCC):
  • intellectual disability, autosomal dominant 9
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • syndromic intellectual disability
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neuropathy, hereditary sensory, type 2C
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • hereditary spastic paraplegia 30
    Inheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • PEHO syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary sensory and autonomic neuropathy type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001244008.2
BP6
Variant 2-240757423-ATCC-A is Benign according to our data. Variant chr2-240757423-ATCC-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 284274.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.824 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KIF1ANM_001244008.2 linkc.2751_2753delGGA p.Glu917del disruptive_inframe_deletion Exon 27 of 49 ENST00000498729.9 NP_001230937.1 Q12756-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KIF1AENST00000498729.9 linkc.2751_2753delGGA p.Glu917del disruptive_inframe_deletion Exon 27 of 49 5 NM_001244008.2 ENSP00000438388.1 Q12756-3

Frequencies

GnomAD3 genomes
AF:
0.646
AC:
88747
AN:
137280
Hom.:
28022
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.831
Gnomad AMI
AF:
0.649
Gnomad AMR
AF:
0.572
Gnomad ASJ
AF:
0.630
Gnomad EAS
AF:
0.713
Gnomad SAS
AF:
0.458
Gnomad FIN
AF:
0.554
Gnomad MID
AF:
0.634
Gnomad NFE
AF:
0.571
Gnomad OTH
AF:
0.637
GnomAD2 exomes
AF:
0.525
AC:
57824
AN:
110140
AF XY:
0.518
show subpopulations
Gnomad AFR exome
AF:
0.773
Gnomad AMR exome
AF:
0.449
Gnomad ASJ exome
AF:
0.573
Gnomad EAS exome
AF:
0.646
Gnomad FIN exome
AF:
0.515
Gnomad NFE exome
AF:
0.538
Gnomad OTH exome
AF:
0.546
GnomAD4 exome
AF:
0.508
AC:
663522
AN:
1306324
Hom.:
129418
AF XY:
0.505
AC XY:
324197
AN XY:
642016
show subpopulations
African (AFR)
AF:
0.725
AC:
21238
AN:
29296
American (AMR)
AF:
0.433
AC:
13543
AN:
31290
Ashkenazi Jewish (ASJ)
AF:
0.555
AC:
12891
AN:
23218
East Asian (EAS)
AF:
0.610
AC:
20320
AN:
33332
South Asian (SAS)
AF:
0.418
AC:
28341
AN:
67860
European-Finnish (FIN)
AF:
0.504
AC:
22004
AN:
43676
Middle Eastern (MID)
AF:
0.544
AC:
2848
AN:
5238
European-Non Finnish (NFE)
AF:
0.505
AC:
514083
AN:
1018318
Other (OTH)
AF:
0.522
AC:
28254
AN:
54096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.551
Heterozygous variant carriers
0
18126
36251
54377
72502
90628
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16338
32676
49014
65352
81690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.647
AC:
88841
AN:
137360
Hom.:
28069
Cov.:
0
AF XY:
0.643
AC XY:
42788
AN XY:
66516
show subpopulations
African (AFR)
AF:
0.832
AC:
31764
AN:
38200
American (AMR)
AF:
0.572
AC:
7645
AN:
13364
Ashkenazi Jewish (ASJ)
AF:
0.630
AC:
2051
AN:
3256
East Asian (EAS)
AF:
0.713
AC:
3310
AN:
4640
South Asian (SAS)
AF:
0.459
AC:
1870
AN:
4070
European-Finnish (FIN)
AF:
0.554
AC:
4941
AN:
8924
Middle Eastern (MID)
AF:
0.629
AC:
171
AN:
272
European-Non Finnish (NFE)
AF:
0.571
AC:
35358
AN:
61926
Other (OTH)
AF:
0.635
AC:
1204
AN:
1896
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1484
2968
4452
5936
7420
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
714
1428
2142
2856
3570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.469
Hom.:
1564

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 21, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Aug 26, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 26, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Nov 12, 2020
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Hereditary spastic paraplegia 30 Benign:1
Jul 17, 2023
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as benign. Following criteria are met: 0308 - Population frequency for this variant is out of keeping with known incidence of spastic paraplegia 30, autosomal recessive (MIM#610357), with 26,739 homozygotes in gnomAD v3. (SB) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -

KIF1A related neurological disorder Benign:1
May 04, 2023
Molecular Genetics, Royal Melbourne Hospital
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

African population allele frequency is 75.16% (rs143816642, 57824/110140 alleles, 11329 homozygotes in gnomAD v2.1). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.6.1, this variant is classified as BENIGN. Following criteria are met: BA1 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
3.2
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10594016; hg19: chr2-241696840; COSMIC: COSV57481902; API